NEW YORK (Reuters) - Medtronic Plc's Covidien unit has agreed to settle some of the more than 11,000 claims involving its transvaginal mesh devices, which patients allege caused severe and painful ...

WASHINGTON (CN) - As reports of serious complications continue to rise, the Food and Drug Administration has issued two orders to manufacturers to strengthen requirements for transvaginal surgical ...

(Reuters) - A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 ...

NEW YORK (Reuters) -Boston Scientific Corp agreed to pay $188.7 million to settle claims by most U.S. states that it deceptively marketed its surgical mesh devices to consumers. The settlement with 47 ...

Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday. The FDA said it "has ...

A federal judge has dismissed a legal malpractice lawsuit against six law firms in New Jersey and Texas accused of using invalid retainer agreements to charge excessive contingency fees for thousands ...

Johnson & Johnson and its Ethicon division have reached a deal with the attorneys general of 41 states and the District of Columbia, agreeing to settle claims that it deceptively advertised and ...

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) ...

The U.S. Food and Drug Administration has issued a proposed rule to reclassify surgical mesh for transvaginal repair of pelvic organ prolapse as a Class III “high-risk device.” The mesh is currently ...

Years of activism have made women’s health a topic of everyday conversation. The mechanics of mammograms and the pros and cons of cervical cancer vaccines are familiar, but one common health problem ...

A nationwide $60 million settlement of a surgical mesh liability case against CR Bard includes New Hampshire and involves a suit in the Granite State. In the case of CR Bard, now owned by Becton ...

Trenton, N.J. – Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women’s sagging pelvic organs.